Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Sale of 12,248 MPLT shares, $96.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 12,248 | $96.0K |
| Aug 19, 2026 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 6,020 | n/a |
| Jul 20, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 5,545 | $200.3K |
| Apr 29, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 8,346 | $241.7K |
| Apr 17, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 3,316 | $88.2K |
| Feb 9, 2026 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 6,020 | n/a |
| Jan 29, 2026 | MapLight Therapeutics, Inc. (MPLT) | Tax Withholding | 42,099 | $756.9K |
| Oct 28, 2025 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 35,953 | n/a |